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Abstract 
From the Western countries a new dangerous phenomenon is approaching the Central 
and Eastern Europe. The pressure on psychical performance while studying and at work is 
becoming that hard that many individuals are reaching for stimulants. When cigarettes, coffee 
and energy drinks do not help anymore, the next in row are compulsory prescription drugs, 
which have been developed for entirely different purposes and which can sometimes have far-
reaching lifelong consequences for the health. This phenomenon is called brain doping or 
cognitive enhancement. 
 
1 Historical background 
It is very difficult to determine exactly when people with no major health problems 
started their cognitive abilities through prescription drugs affect. However, as a raised finger 
appears an article in The New York Times of May 15th, 1996. The author Gina Kolat drew 
attention to more than 500-percent increase in the prescription drug Ritalin, which is currently 
perhaps the most commonly used in cognitive enhancement. Even then began a debate in 
America on the ethics of the use of pharmaceuticals to improve human mental abilities. 
Cognitive enhancement, among other things, was also mentioned in two well-known 
and highly successful American television series. On The Simpsons (Fox), son Bart 
discovered the conspiracy of the American Baseball League thanks to the imaginary drug 
Focusin and on Desperate Housewives (ABC), the main character Lynette succumbed to 
drugs that were designed to treat the hyperactivity of her children - twins. 
2 Definition of cognitive enhancement 
In the literature there are many terms used for cognitive enhancement. There is for 
example brain doping, brain enhancement, mind doping, psycho enhancement, cosmetic 
psychofarmacology or neuro enhancement among the most common. 
 Brain doping refers to non-medically indicated administration of drugs that were 
developed for patients with dementia, depression, attention deficit disorder or narcolepsy.1 
Neuro-enhancement is a targeted measure to improve mental ability or mental well-
being in healthy people.2 
The cognitive enhancement is a targeted influence of human cognitive abilities 
through active substances, which are primarily designed to treat mainly psychological 
disorders and medications containing them are only on prescription. 
 
3 Current status 
Current status in the field of cognitive enhancement is very difficult to estimate. 
Lacking are credible studies that examine the usage of active substances exploited for 
cognitive enhancement on healthy subjects. The current studies largely follow the use of 
cognitive enhancement in a single country or a specific target group. 
A large number of experts warn that when the market of sick people is for a large 
pharmaceutical company interesting, what will be, if the market turns into the market of 
healthy people, who want to modify their cognitive abilities. 
In December 2002, the Forbes magazine listed in the article titled "Viagra for the 
brain" a list of pharmaceutical companies that got the gusto to research drugs that are abused 
for cognitive enhancement. In addition to giants such as GlaxoSmithKline, Merck, Johnson & 
Johnson and Pfizer, in the list appeared a number of companies whose names are completely 
unknown. Examples include the companies Cortex, Helicon Therapeutics, Memory 
Pharmaceuticals and Axonyx. The last named company was founded by the Nobel Prize 
laureate for Medicine (2000) Eric R. Candelas, and in 2008 it was purchased for $ 50 million 
by the Swiss pharmaceutical giant Roche. 
Most of these companies already test their products on volunteers in the U.S. and 
about the drugs called CX516, SB271046 or Gilatide we will certainly hear more soon. 
                                                 
1 Groß, D.: Neuro-Enhancement unter besonderer Berücksichtigung neurobionischer Maßnahmen. Anmerkungen 
aus ethischer sicht. in Wienke, A. – Eberbach, W. H. – Kramer, H.-J. – Janke, K.: Die Verbesserung des 
Menschen: Tatsächliche und rechtliche Aspekte der wunscherfüllenden Medizin. Springer, 2009. pp. 88 
2 Schöne-Seifert, B. – Talbot, D.: Neuro Enhancement – Ethik vor neuen Herausforderungen. 1. Auflage. 
Paderborn: Mentis, 2009. pp. 9. 
 The market value of the so-called "Lifestyle Drugs", whose role is not the medical 
treatment but the improvement of the quality of life, was in 2007 estimated worldwide at $ 29 
billion. The tendency is obviously rising. 
 
4 Main reasons for the use of cognitive enhancement 
Experts in particular areas of psychiatry and psychology see different reasons for 
cognitive enhancement concerning the older and younger generations. Elderly people 
naturally have a loss of so-called fluid intelligence, which is responsible for ensuring that we 
can still control the recent advances in technology. It is at present the modern era is given to 
the fluid intelligence of great importance, although it is not a condition in any personal 
advertisement. The smooth control of a computer or mobile phone, even the latest generation, 
is taken for granted by employers. 
Concerning the younger generation the psychiatrists and psychologists see the problem 
in particular of the increased pressure for mental performance. A good example is the annual 
number of law graduates in the Slovak republic. The competition is huge and the number of 
job opportunities is indeed little. Only the strongest survive in the jungle and in the field of 
law muscles do not play any role at all. Therefore the brain must be doped. 
Moreover, the target groups should be divided by gender. While men go after 
cognitive enhancement in order to increase their existing performance, by nature more stable 
(grown) women seek particular the mental balance. 
 
5 The main target groups 
Generally speaking, brain doping mainly concerns people who need mental exercise 
and to be mentally fit. Within this group, there are other subgroups. 
 
a) Schoolchildren 
In the Northern America and the Western Europe, the number of cases increase, where 
there is abuse of pharmaceutical preparations at a very young generation. From the youth a 
man learns that in modern society he is defined by its performance. Often, the children do not 
dope by themselves, but they are doped by their parents. They know that a good present 
performance can open various doors in the future. 
 A child with good grades in elementary school will have an easier way to a good high 
school. Maybe later with an excellent performance it will become a scholarship on a generally 
recognized or even on an elite university and ends up with a well-paid job at a multinational 
enterprise. 
In the United States even the concept of "Ritaline parties" appeared, by the name 
derived from one of the pharmaceuticals, which are often used for brain doping. 
The American pediatrician Lawrence Diller has warned long ago that "the American 
psychiatric community is shifting its focus from blaming the mother to blaming the brain." In 
his point of view, cases are increasing, in which drugs affect the brain are taken by three to 
four year olds children, which he called "scary". 
 
b) Students 
Technology, medicine and law: these are the most fields of study, in which cognitive 
enhancement appears in developed countries. Students are even higher due to major reforms 
in the European Union, forced to submit more thorough and better performances. Some of 
them, who can not keep up, help the brain with chemical interventions with the help of drugs. 
In the UK, students who like to help themselves by chemical interference into the 
brain processes, must worry about the current debate. In the country there are considerations 
about drug tests before the tests in the universities. Most of the cognitive enhancement 
preparations cause a positive test. 
 
c) Managers and employees at all 
The current economic crisis only accelerated a process that has long been in the most 
important market economies. The bar for performance is built every year and jump above this 
threshold is not always easy. Especially when the body terminates the service and makes it 
clear that the limit has been reached. The manager or the employee ends up with a burn out. 
Overcoming the limits is long ago not the prerogative only of athletes. An employee 
who is able to work twelve instead of standard ten hours is a dream of every employer and has 
a huge competitive advantage over his colleagues. But only until the others discover the secret 
of his success. 
 
 
 
 
 d) Woman 
As psychiatrists as doctors, but also psychologists as philosophers agree that women 
are a completely different target group of cognitive enhancement. Indeed, while for men it is 
essential to have a maximal performance, for women is a central issue their mental balance. 
Women who feel overburdened, matters more than their current mood that fail to meet certain 
requirements expected from them. 
The thesis is proved by several known statistics that point to the fact that men 
increasingly resorting to stimulants that encourage performance, while women reach after 
drugs which affect the individual's mental state. 
 
6 The most commonly used active substances and drugs 
Most cognitive enhancing drugs improve only specific aspects of cognition such as 
forms of executive functions or memory, which are mediated by different system in the 
brain.3 
 
a) Methylphenidate 
Perhaps the most widely used drug in the field of cognitive enhancement is a product 
of the company Ciba-Geigy (now part of Novartis Group), called Ritalin. It was developed to 
combat the hyperactivity syndrome and the treatment of ADHD (Attention Deficit 
Hyperactivity Disorder), which is the most common psychiatric disorder of children. Ritalin 
appeared on the market already in 1950. It contains the active substance methylphenidate, 
which is a derivative of amphetamine. The drug does not calm the patient down, but it causes 
a secretion of the happiness hormone dopamine in the brain. In addition to Ritalin the active 
substance methylphenidate is included in drugs such as Concerta, Methylin, Metadate and 
Daytrana patch. 
 
 
 
 
 
                                                 
3 Morein-Zamir, S. – Robbins, T. – Turner, D. – Sahakian, B. J.: Pharmacological cognitive enhancement. in 
Cooper, C. L. – Goswami, U. –Sahakian, B. J.: Mental Capital and Wellbeing. John Wiley and Sons, 2009. ISBN 
978-1-4051-8591-2. pp. 1040. 
 b) Modafinil 
Another active substance that is used on cognitive enhancement is modafinil. In the 
medicine it is used to treat narcolepsy, a chronic neurological disorder caused by the inability 
of the brain normally regulate sleep cycles and normal waking state. 
This substance, however, healthy subjects discovered to help them by recasting the 
whole night without any major signs of fatigue. Modafinil is included in drugs such as 
Provigil (Vigil), Alertec, Modavigil, Modalert, Modiodal, Modafinil, or Carima. 
 
c) Denepezil 
Denepezil is an active substance used in the treatment of some geriatric diseases and to 
prevent the continuation of the mental declines of demented patients. Even medications, of 
which the most famous is Aricept, already found their way among healthy people who want to 
increase the brain performance and memory support. 
 
d) Metoprolol 
Even against stage-fright, some individuals found a recipe in the form of prescription 
drugs. It contains the active substance metoprolol, belong to a group of beta-blockers and 
their primarily designation is the treatment of heart disease. Metoprolol causes that almost 
every vegetative controlled body process slows down. This does not however concerns 
thinking, and so some of these drugs help against the feelings of stage fright, fear and mental 
tension. 
 
e) Antidepressants and anti-dementia drugs 
The last major group of drugs that is abused in the field of cognitive enhancement is 
the group of antidepressants and anti-dementia drugs. Active substances in this case are 
fluoxetine and piracetam. 
 
7 The main problem of cognitive enhancement 
The biggest problem in the cognitive enhancement is that people, who use it, consider 
its benefits for more than its risks. On the black market drugs that are otherwise strictly on 
prescription, are usually sold in pieces, and not as a whole package. The user does not 
therefore usually get the package leaflet, which is very important. The interest on the 
preparation certainly fall, if a potential user read the following paragraph in which the most 
 common and most serious side effects are listed. The list belongs to a drug, which is also 
abused for the cognitive enhancement. 
 
An example of the side effects4 
The most common side effects are nervousness, somnolence and headache. 
Some side effects can be serious. If you have any of the following side effects or if 
these side effects worsen, tell your doctor or pharmacist: 
 significant changes in mood or personality 
 mania 
 psychotic disorders, including visual, tactile or auditory hallucinations or 
pretenses, 
 palpitations, unexplained fainting, chest pain, shortness of breath (sometimes these 
may be signs of heart disease), 
 paralysis or impaired movement and vision, speech problems (could be symptoms 
of cerebral vasculitis). 
 
All scientists, involved in the issue of cognitive enhancement, also point to the fact 
that the drugs were not tested on healthy subjects, but ill patients. 
Another problem is that on the black market a user can not be sure of the originality of 
the drug. In best case, one takes a placebo pill; therefore, without any active substance that is 
only the face and taste of a medicine. Nothing will happen, but also the desired effect will not 
appear. In the worst case side effects occur, which may not even resemble the above, and may 
extend their severity. 
 
8 Cognitive enhancement in the Slovak republic 
Cognitive enhancement begins to slowly wade even in the Slovak republic. The first 
target group was found to be the university students. The proof can be found on the internet 
forum of the Technical University of Kosice (www.te-ke.com), where a user with the 
nickname "The Pharmacist" offers for sale drugs Lucetam, Pirabene and Ritalin. He promises 
an up to 20 percent higher intelligence quotient after taking these drugs and a rapid reduction 
of the time to learn (from few days to only few hours). On the question of the price was the 
                                                 
4 Slovak State Institute for Drug Control. online: http://www.sukl.sk. as of September, 1st 2010. 
 pharmacist a good trader with a larger. With a higher quantity he offered some discount. One 
pill so could be bought by a student from the price of € 1.66. 
In the academic year 2011/2012 as a part of the research project VEGA # 315 
(Scientific Grant Agency of the Ministry of Education, Science, Research and Sports of the 
Slovak republic and the Slovak Academy of Sciences), a research in one of the business 
centers in the capital city Bratislava is planed. It aims to clarify the approximate degree of 
extension of the brain doping in the Slovak Republic. 
 
9 Anticipated development 
In America and the Western Europe, the debate about brain doping shifted the level 
below. Question not already know "to use or not to use?" but "If so, does anyone have the 
right for the brain doping equally?" 
In practice this would mean that the availability of drugs for cognitive enhancement 
should begin to participate in health insurance. Improved performance would no longer be 
solely those who have high income or who can obtain through illegal means. 
To this situation, however, still leads a very long way. First to go through the many 
long-term medical and pharmaceutical studies show that for healthy individuals are not drugs 
with active ingredients such as methylphenidate or modafinil dangerous and have no serious 
side effects. 
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